Navigation Links
Echo Therapeutics Reports Third Quarter 2007 Results

488,650 103,365

Total current liabilities 915,248 284,823

Notes Payable, net of current portion - 54,508


Stockholders' Equity

Series A Convertible Preferred Stock,

$0.01 par value, authorized

7,000,000 shares, issued and

outstanding no shares at

September 30, 2007 and 73,334

shares at December 31, 2006 - 76,291

Common stock, $0.01 par value,

authorized 60,000,000 shares,

issued and outstanding

17,707,679 shares at September

30, 2007 and 2,776,192 shares

at December 31, 2006 177,079 27,762

Additional paid-in capital 56,494,899 34,822,306

Accumulated deficit (44,738,545) (34,460,661)

Total stockholders' equity 11,933,433 465,698

Total liabilities and

stockholders' equity $12,848,681 $805,029

Echo Therapeutics, Inc.

(Formerly Sontra Medical Corporation)

Consolidated Statements of Operations


Three Months Ended Nine Months Ended

September 30, September 30,

2007 2006 2007 2006


Product revenues $ - $10,679 $12,120 $37,619

Licensing revenue 12,500 12,500 37,500 37,501

Total revenue 12,500 23,179 49,620 75,120

Operating Expenses:

Cost of product

revenue - 9,445 1,556 61,734

Research and


SOURCE Echo Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
3. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
4. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
5. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
6. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
9. Amsterdam Molecular Therapeutics Reports Half Year Results 2007
10. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
11. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
Post Your Comments:
(Date:7/10/2014)...  Kainos Capital, a firm specializing in acquiring and ... has acquired the Slim-Fast brand from Unilever. Unilever will ... the transaction were not disclosed. Slim-Fast is ... markets ready-to-drink shakes, powders, bars and snacks to retail ... in the United Kingdom and ...
(Date:7/10/2014)... Adelaide research may help in the fight against terrorism ... tiny quantities of explosives with the use of light ... Sensors and Actuators B: Chemical , the researchers ... explosives in concentrations as low as 6.3 ppm (parts ... a few minutes. , "Traditionally explosives detection has involved ...
(Date:7/10/2014)... RICHLAND, Wash. The lithium-ion batteries that power our ... run longer on a single charge with the help ... the porous material to replace the graphite traditionally used ... more than 10 times the energy storage capacity of ... lithium-ion battery electrode was published today in Nature ...
(Date:1/15/2014)... a club sandwich at the nanoscale, National Institute ... in crafting a uniform, multi-walled carbon-nanotube-based coating that ... in upholstered furniture and other soft furnishings. , ... reduced 35 percent compared with untreated foam. As ...
Breaking Biology Technology:Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2Silicon sponge improves lithium-ion battery performance 2Silicon sponge improves lithium-ion battery performance 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2
... David P. Wright, Co-Chair of the Alliance for ... testified today before the House Labor, Health and ... critical importance of developing drugs, vaccines and other ... and other catastrophic health emergencies. Effective medical countermeasures ...
... to Enable BBK Worldwide to Better Serve Asia-Pacific ... BBK Worldwide, a global leader in patient recruitment ... BBK Worldwide -- Osaka, G.K., in Osaka, Japan. ... pharmaceutical, biotechnology, and medical device companies, as well ...
... 18 Sopherion Therapeutics, LLC, a biopharmaceutical company ... therapies, announced that it completed enrollment in its ... (Myocet(TM)) in metastatic HER-2-overexpressing breast cancer. This ... lead product in combination with the current standard ...
Cached Biology Technology:Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 2Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace 3Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer 2Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer 3
(Date:7/11/2014)... This news release is available in German . ... imaging is a method that uses the refraction of ... absorption. The images produced with this method are often ... The scientists in the team of Prof. Franz Pfeiffer ... X-ray imaging and therapy including X-ray phase-contrast imaging. ...
(Date:7/11/2014)... develop relationships with other group members to reduce aggression ... baboons the strategy for grooming activities shows a certain ... in the scientific journal Biology Letters . , ... not practiced without ulterior motives. To be groomed has ... while grooming another individual can provide access to infants, ...
(Date:7/11/2014)... transplantation of mesenchymal stem cells can stimulate neurogenesis in ... Alzheimer,s disease (AD) and improve tissue and function injury ... reported on the therapeutic effect of adipose-derived stem cells ... effect on oxidative injury and neurogenesis in the brain ... School of Life Sciences, Tsinghua University, China transplanted ADSCs ...
Breaking Biology News(10 mins):New simple setup for X-ray phase contrast 2Baboons groom early in the day to get benefits later 2
... predicted that tree species will respond to global warming ... a new study of 65 different species in 31 ... Nearly 80 percent of the species aren,t yet ... staying in place -- but speeding up their life ...
... Nio Southern Oscillation (ENSO), altering the cycles of El Nio ... to Australia and many other Pacific-rim countries., New research published ... has revealed how the ENSO cycle has changed over the ... an impact on the strength and timing of El Nio ...
... of multiple sclerosis, a debilitating disease that affects up to ... researchers and medical professionals for generations. But Steven Schutzer, a ... now found an important clue why progress has been slow ... MS has focused on the wrong part of the brain. ...
Cached Biology News:Climate change may speed up forests' life cycles 2Global warming could change strength of El Niño 2Multiple sclerosis appears to originate in different part of brain than long believed 2Multiple sclerosis appears to originate in different part of brain than long believed 3
... gun system, 100-120 V, is used for ... This handheld device employs an adjustable helium ... biomaterial-coated gold microcarriers from the inner wall ... target cells. This system has a 2 ...
... Conjugated peptides, recombinant or native proteins are used ... immunization protocol optimized in time, quantity of antigen ... the use of 2 animals per protocol in ... yield on a 77-day protocol is approximately 75 ...
Mouse monoclonal antibody raised against a partial recombinant DHX8. NCBI Entrez Gene ID = DHX8...
... binding specificity and signaling of the members ... be modified by alternative splicing--which has important ... you can perform a classical expression profiling ... different alternatively spliced forms of the gene ...
Biology Products: